Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

An overview on tuberculosis-specific hospitals in China in 2009: results of a national survey

Yu Pang, Jian Du, Zhi Zhen Qin, Zoë Greenwald, Yuhong Liu, Fengling Mi, Yanlin Zhao, Liang Li
European Respiratory Journal 2016 47: 1584-1587; DOI: 10.1183/13993003.01854-2015
Yu Pang
1Beijing Chest Hospital, Capital Medical University, Beijing, China
2Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China
3Administration Office, Clinical Center on Tuberculosis, Chinese Center for Disease Control And Prevention, Beijing, China
4National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
7These authors contributed equally to this paper
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian Du
1Beijing Chest Hospital, Capital Medical University, Beijing, China
2Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China
3Administration Office, Clinical Center on Tuberculosis, Chinese Center for Disease Control And Prevention, Beijing, China
7These authors contributed equally to this paper
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi Zhen Qin
5Dept of Epidemiology and Biostatistics, McGill University, Montreal, Canada
6Stop TB Partnership, Geneva, Switzerland
7These authors contributed equally to this paper
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zoë Greenwald
5Dept of Epidemiology and Biostatistics, McGill University, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuhong Liu
1Beijing Chest Hospital, Capital Medical University, Beijing, China
2Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China
3Administration Office, Clinical Center on Tuberculosis, Chinese Center for Disease Control And Prevention, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fengling Mi
1Beijing Chest Hospital, Capital Medical University, Beijing, China
2Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China
3Administration Office, Clinical Center on Tuberculosis, Chinese Center for Disease Control And Prevention, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanlin Zhao
4National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liang Li
1Beijing Chest Hospital, Capital Medical University, Beijing, China
2Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China
3Administration Office, Clinical Center on Tuberculosis, Chinese Center for Disease Control And Prevention, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: liliang69@tb123.org
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

TB hospitals are critical for control of DR-TB, hence strengthened collaboration with public health systems is needed http://ow.ly/YnikY

To the Editor:

As of 2014, tuberculosis (TB) was the deadliest infectious disease worldwide and China has the third-highest TB burden [1]. In that year alone there were 826 155 new cases in China [1]. In addition, China has been experiencing a serious epidemic of drug-resistant TB [2, 3].

The availability of adequately equipped microbiology laboratories is an essential element of effective TB control [4, 5]. The Chinese National Center for TB control (NCTB), which was organised through the public health system throughout the 1990s and early 2000s, invested in this area. As many as 3490 TB dispensaries were established [6]. In 2005, $1.3 billion was invested to rebuild 2448 dispensaries and scale up new TB tests such as liquid culture [7, 8].

Since early 2000, the NCTB programme has been moving TB care towards a hospital-based management model which mandates tuberculosis-specific hospitals to diagnose and treat TB patients [8]. These hospital are public hospitals or health facilities and are designated by their local authority to clinically manage TB patient. Variants include TB hospitals, chest hospitals and infectious disease hospitals, etc. [8]. At the moment, there is little knowledge regarding the testing capacity of laboratories within these hospitals. Additionally, there is also little data about the prevalence of multi drug-resistant TB (MDR-TB) in tuberculosis-specific hospitals. The latest national MDR-TB survey in China was conducted only in TB dispensaries, i.e. within the public health system. In this study, we aim to address the aforementioned issues by conducting a national survey in microbiology laboratories in tuberculosis-specific hospitals in 2009.

The survey was conducted using a standardised questionnaire designed by the National Tuberculosis Clinical Center. We collected cross-sectional information from all 203 tuberculosis-specific hospitals in China in existence in 2009 with at least 30 beds in TB wards. The study was conducted in 31 provinces, municipalities, and autonomous regions, with questionnaires completed by directors of TB/respiratory department, physicians, and laboratory technicians. A training course for data collection officials was held at the National Tuberculosis Clinical Center to ensure data integrity.

The questionnaire gathered information on the usage of four TB tests, and the number of drug-resistant TB cases diagnosed. The four tests include sputum smear microscopy, solid and liquid culture, and phenotypic drug susceptibility test (DST), which are recommended by the 2008 National Guidelines [9]. Because other tests, such as nucleic acid amplification test, were not approved in China for detection of TB between 1999 and 2009, data on these tests had not been regularly collected by TB hospitals and could not be included. Testing capacity data for the 203 tuberculosis-specific hospitals was retrieved for the year 2004 and 1999. Overall test volume per hospital and average number of tests performed per hospital were recorded on an annual basis. Since these hospitals had not participated in external quality assessment until 2010, we had no data on the quality of the tests performed by the time of the survey. To guarantee the robust nature of the results, 20% of the questionnaires were cross-checked with original hospital records obtained from the relevant Provincial Bureau of Health. Discrepancies were resolved by telephone interviews.

Of the 203 TB-specific hospitals surveyed, 198 (98%) had the capacity to conduct smear microscopy in 2009 (table 1), thereby indicating this was the most widely used diagnostic test. Roughly 60% of tuberculosis-specific hospitals had the capacity to perform solid culture and/or a DST in 2009. Liquid culture, however, were much less common; only 62 hospitals (31% of the total) were able to conduct liquid culture in 2009 as biological safety level 3 is required for the labs to conduct liquid culture [10]. Nevertheless, it should be noted that the ability to conduct liquid culture had been quickly growing. Between 1999 and 2009, the number of hospitals capable of performing this test had increased from 20 to 62, an improvement in alignment with the ambition of the China National Plan for 2006–2010 [11]. The development of TB laboratory capacity was also impressive in other respects. There were 1.2-times the number of TB-specific hospitals capable of performing microscopy smear testing in 2009 than in 1999, 1.3-times the number of such hospitals that could perform solid culture and 1.5-times the number of TB-specific hospitals that could undertake a DST.

View this table:
  • View inline
  • View popup
TABLE 1

National survey of the 203 TB-specific hospitals in China from 1999 to 2009

In addition to analysing the capability of TB-specific hospitals to conduct each specific type of test, we also considered the total numbers of each test conducted in 2009. In terms of the average annual number of tests performed in each TB-specific hospital (with that particular capability), there were a slightly higher number of liquid culture (n=1844) performed per hospital than solid culture (n=1259). Only 428 drug susceptibility tests were performed per hospital. Overall annual test throughput per hospital also increased significantly between 1999 and 2009, especially for a DST, where there was a 1.4 times increase in the number of tests per hospital.

A total of 1304 laboratory technicians were employed in the 203 hospitals in 2009, which meant that there were, on average, 6.4 technicians at each hospital. However, there was a geographic variation in the distribution of lab technicians; the highest number was in the West (7.8 technicians per hospital), compared with a relatively lower number in the East (6.3 technicians per hospital) and in the centre (6.2 technicians per hospital). The West also had the highest number of cases of pulmonary TB which may be the result of large workload in that area. There were more technicians per lab in TB-specific hospitals than there were in public health system institutions, which had only roughly 5 lab technicians per lab at provincial level and 1–2 technicians per lab at prefectural level [12]. This is not surprising given that salaries are generally lower in the public health system.

The data on drug-resistant TB in tuberculosis-specific hospitals was only available for the period since 2007, after which drug-resistant TB was diagnosed in TB-specific hospitals using conventional DST. The overall number of these tests increased by 63.1% between 2007 and 2009. The percentages of cases of drug-resistant TB and MDR-TB, among those tested for DST, stood at 33.9% and 17.8% respectively, in 2007, 34.9% and 18.6% respectively, in 2008, and 33.8% and 17.8% respectively, in 2009. There was no significant increase in the proportions of drug-resistant TB or MDR-TB among those tested for DST from 2007 to 2009 (p>0.05).

A recent national survey on drug-resistant TB revealed that 8.3% of smear-positive TB patients tested for drug susceptibility had MDR TB in the public health system in 2007 [13]. In this study, we found the comparable statistic to be 17.8% in TB-specific hospitals in 2009, which was about two times that in the public health system 2 years previously. This indicates the important role that is played by TB-specific hospitals in drug-resistant TB and MDR-TB treatment management. Previous studies have demonstrated that the abuse of anti-TB drugs, especially second-line drugs, is an ongoing area of concern in TB-specific hospitals [14, 15]. Given the high level of prevalence of drug-resistant TB within tuberculosis-specific hospitals, it is imperative that moves are made to ensure a standardised treatment regimen for drug-resistant TB and MDR-TB patients across both systems. An integral element of this will be to strengthen follow-up processes within the tuberculosis-specific hospitals.

Acknowledgements

We are grateful to all the local participants for their help throughout this survey. The authors are grateful to Jacob Creswell, Team Leader at TB REACH, Stop TB Partnerships, Geneva, Switzerland, for his critical review.

Footnotes

  • Support statement: This study was supported by the National Health and Family Planning Commission.

  • Conflict of interest: None declared.

  • Received June 18, 2015.
  • Accepted January 19, 2016.
  • Copyright ©ERS 2016

References

  1. ↵
    World Health Organization. Global Tuberculosis Report. Geneva, WHO Press, 2015. Available from www.who.int/tb/publications/global_report/en/
  2. ↵
    1. Pang Y,
    2. Zhou Y,
    3. Zhao B, et al.
    Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One 2012; 7: e32976.
    OpenUrlCrossRefPubMed
  3. ↵
    World Health Organization. Global Update on the Health Sector Response to HIV, 2014. Geneva, WHO Press, 2014. Available from www.who.int/hiv/pub/progressreports/update2014/en/
  4. ↵
    World Health Organization. Strategic Approach for the Strengthening of Laboratory Services for Tuberculosis Control. Geneva, World Health Organization, 2006.
  5. ↵
    1. Paramasivan CN,
    2. Lee E,
    3. Kao K, et al.
    Experience establishing tuberculosis laboratory capacity in a developing country setting. Int J Tuberc Lung Dis 2010; 14: 59–64.
    OpenUrlPubMed
  6. ↵
    National Health and Family Planning Commission (NHFPC) of the People's Republic of China. China Health and Family Planning Statistics Yearbook. Beijing, Peking Union Medical College Press, 2013.
  7. ↵
    1. Wang L,
    2. Liu J,
    3. Chin DP
    . Progress in tuberculosis control and the evolving public-health system in China. Lancet 2007; 369: 691–696.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    Ministry of Health of the People's Republic of China. National Tuberculosis Control Programme (2011–2015). Beijing, Ministry of Health, 2011.
  9. ↵
    Department of Disease Control, Department of Medical Administraton, Chinese Center for Disease Control and Prevention. Guidelines for Implementing the National Tuberculosis Control Program in China. Beijing, 2008.
  10. ↵
    Ministry of Health of the People's Republic of China. A List of Human Pathogenic Microorganisms. Beijing, Ministry of Health, 2006.
  11. ↵
    Ministry of Health of the People's Republic of China. National Tuberculosis Control Programme (2006–2010). Beijing, Ministry of Health, 2006.
  12. ↵
    1. Chen S,
    2. Liu B,
    3. Wang X, et al.
    Analysis of human resource situation about TB control in Zhejiang. Chin J Antituberc 2006; 28: 345–347.
    OpenUrl
  13. ↵
    1. Zhao Y, et al.
    National survey of drug-resistant tuberculosis in China. N Engl J Med 2012; 366: 2161–2170.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Li W,
    2. Sun Q,
    3. Yan Y, et al.
    Investigation of the second line anti TB drugs usage in specialist hospitals and tuberculosis control institutions. Chin J Antituberc 2010; 32: 706–709.
    OpenUrl
  15. ↵
    1. Liu X,
    2. Wang L,
    3. Du Y, et al.
    Current status of case referring and treatment of tuberculosis inpatients in four tuberculosis specialist hospitals in China. Chin J Antituber 2010; 32: 775–778.
    OpenUrl
PreviousNext
Back to top
View this article with LENS
Vol 47 Issue 5 Table of Contents
European Respiratory Journal: 47 (5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An overview on tuberculosis-specific hospitals in China in 2009: results of a national survey
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
An overview on tuberculosis-specific hospitals in China in 2009: results of a national survey
Yu Pang, Jian Du, Zhi Zhen Qin, Zoë Greenwald, Yuhong Liu, Fengling Mi, Yanlin Zhao, Liang Li
European Respiratory Journal May 2016, 47 (5) 1584-1587; DOI: 10.1183/13993003.01854-2015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
An overview on tuberculosis-specific hospitals in China in 2009: results of a national survey
Yu Pang, Jian Du, Zhi Zhen Qin, Zoë Greenwald, Yuhong Liu, Fengling Mi, Yanlin Zhao, Liang Li
European Respiratory Journal May 2016, 47 (5) 1584-1587; DOI: 10.1183/13993003.01854-2015
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Agora

Research letters

  • Impact of depression and anxiety on exacerbation risk in bronchiectasis
  • Respiratory management of drowning-associated ARF
  • Mitochondrial DNA as biomarker of survival in RA-ILD
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society